The IMS® Oncology Analyzer (Taiwan) is the second in a series of IMS® Oncology Analyzer databases we are adding to our resource. Potential uses of this database include help with: (1) Determining patient segmentation and targeting based on actual clinical practice; (2) Sizing the market accurately to assess brand potential; (3) Monitoring brand performance, new product uptake and therapy adoption globally; (4) Evaluating treatment flows from diagnosis to current therapy; and (5) Benchmarking against competitor performance.
See a list of all 242 databases profiled here.